Lymphatic endothelium contributes to colorectal cancer growth via the soluble matrisome component GDF11.


Journal

International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124

Informations de publication

Date de publication:
01 10 2019
Historique:
received: 06 07 2018
revised: 25 01 2019
accepted: 28 02 2019
pubmed: 20 3 2019
medline: 18 1 2020
entrez: 20 3 2019
Statut: ppublish

Résumé

Colorectal cancer (CRC) is one of the most malignant tumors worldwide. Stromal cells residing in the tumor microenvironment strongly contribute to cancer progression through their crosstalk with cancer cells and extracellular matrix. Here we provide the first evidence that CRC-associated lymphatic endothelium displays a distinct matrisome-associated transcriptomic signature, which distinguishes them from healthy intestinal lymphatics. We also demonstrate that CRC-associated human intestinal lymphatic endothelial cells regulate tumor cell growth via growth differentiation factor 11, a soluble matrisome component which in CRC patients was found to be associated with tumor progression. Our data provide new insights into lymphatic contribution to CRC growth, aside from their conventional role as conduits of metastasis.

Identifiants

pubmed: 30889293
doi: 10.1002/ijc.32286
doi:

Substances chimiques

Bone Morphogenetic Proteins 0
GDF11 protein, human 0
Growth Differentiation Factors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1913-1920

Informations de copyright

© 2019 UICC.

Auteurs

Federica Ungaro (F)

IBD Center, Laboratory of Gastrointestinal Immunopathology, Humanitas Clinical and Research Center, Milan, Italy.
Department of Biomedical Sciences, Humanitas University, Milan, Italy.

Piergiuseppe Colombo (P)

Department of Pathology, Humanitas Clinical and Research Center, Milan, Italy.

Luca Massimino (L)

Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.

Giovanni Stefano Ugolini (GS)

Department of Electronics, Information and Bioengineering, Milan, Italy.

Carmen Correale (C)

IBD Center, Laboratory of Gastrointestinal Immunopathology, Humanitas Clinical and Research Center, Milan, Italy.

Marco Rasponi (M)

Department of Electronics, Information and Bioengineering, Milan, Italy.

Valentina Garlatti (V)

Department of Biomedical Sciences, Humanitas University, Milan, Italy.

Federica Rubbino (F)

Department of Biomedical Sciences, Humanitas University, Milan, Italy.

Carlotta Tacconi (C)

Institute of Pharmaceutical Sciences, Pharmacogenomics, Swiss Federal Institute of Technology (ETH), Zurich, Switzerland.

Paola Spaggiari (P)

Department of Pathology, Humanitas Clinical and Research Center, Milan, Italy.

Antonino Spinelli (A)

Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Colon and Rectal Surgery Unit, Humanitas Clinical and Research Center, Milan, Italy.

Michele Carvello (M)

Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Colon and Rectal Surgery Unit, Humanitas Clinical and Research Center, Milan, Italy.

Matteo Sacchi (M)

Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Colon and Rectal Surgery Unit, Humanitas Clinical and Research Center, Milan, Italy.

Salvatore Spanò (S)

IBD Center, Laboratory of Gastrointestinal Immunopathology, Humanitas Clinical and Research Center, Milan, Italy.
Department of Biomedical Sciences, Humanitas University, Milan, Italy.

Stefania Vetrano (S)

IBD Center, Laboratory of Gastrointestinal Immunopathology, Humanitas Clinical and Research Center, Milan, Italy.
Department of Biomedical Sciences, Humanitas University, Milan, Italy.

Alberto Malesci (A)

Department of Medical Biotechnologies and Translational Medicine, University of Milan, Milan, Italy.
Department of Gastroenterology, Humanitas Clinical and Research Center, Milan, Italy.

Laurent Peyrin-Biroulet (L)

Institut National de la Santé et de la Recherche Médicale U954 and Department of Gastroenterology, Nancy University Hospital, Lorraine University, Nancy, France.

Silvio Danese (S)

IBD Center, Laboratory of Gastrointestinal Immunopathology, Humanitas Clinical and Research Center, Milan, Italy.
Department of Biomedical Sciences, Humanitas University, Milan, Italy.

Silvia D'Alessio (S)

IBD Center, Laboratory of Gastrointestinal Immunopathology, Humanitas Clinical and Research Center, Milan, Italy.
Department of Biomedical Sciences, Humanitas University, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH